This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bartella, V. Articles by Surmacz, E. Search for Related Content PubMed PubMed Citation Articles by Bartella, V. Articles by Surmacz, E.

Insulin-Dependent Leptin Expression in Breast Cancer Cells

¹ Sbarro Institute for Cancer Research and Molecular Medicine, Temple University, Philadelphia, Pennsylvania; ² Department of Pharmaco-Biology, University of Calabria, Cosenza, Italy; ³ Department of Surgical and Oncological Sciences, Section of Medical Oncology, University of Palermo, Palermo, Italy; and ⁴ Department of Medical Oncology, University of Verona, Verona, Italy

Requests for reprints: Eva Surmacz, Sbarro Institute for Cancer Research and Molecular Medicine, 1900 North 12th Street, BioLife Building, Room 446, Philadelphia, PA 19122. Phone: 215-204-0306; Fax: 215-204-0303; E-mail: surmacz{at}temple.edu.

Key Words: leptin • insulin • Sp1 • HIF-1 • breast cancer

Pathologic conditions associated with hyperinsulinemia, such as obesity, metabolic syndrome, and diabetes, seem to increase the risk of breast cancer. Here, we studied molecular mechanisms by which insulin activates the expression of leptin, an obesity hormone that has been shown to promote breast cancer progression in an autocrine or paracrine way. Using MDA-MB-231 breast cancer cells, we found that (a) insulin stimulated leptin mRNA and protein expression, which was associated with increased activation of the leptin gene promoter; (b) insulin increased nuclear accumulation of transcription factors hypoxia inducible factor (HIF)-1 and Sp1 and their loading on the leptin promoter; (c) small interfering RNA (siRNA)-mediated knockdown of either HIF-1 or Sp1 significantly down-regulated insulin-induced leptin mRNA and protein expression; further inhibition of leptin expression was observed under the combined HIF-1 and Sp1 siRNA treatment; (d) inhibition of extracellular signal-regulated kinase (ERK)1/2 and phosphatidylinositol-3-OH kinase (PI-3K) pathways significantly, albeit partially, decreased insulin-dependent leptin mRNA and protein expression, which coincided with reduced association of HIF-1 and/or Sp1 with specific leptin promoter regions; and (e) inhibition of ERK1/2 reduced recruitment of both HIF-1 and Sp1 to the leptin promoter, whereas down-regulation of PI-3K influenced only HIF-1 binding. In summary, our data suggest that hyperinsulinemia could induce breast cancer progression through leptin-dependent mechanisms. In MDA-MB-231 cells, this process requires Sp1- and HIF-1–mediated leptin gene transcription and is partially regulated by the PI-3K and ERK1/2 pathways. [Cancer Res 2008;68(12):4919–27]

This article has been cited by other articles:

				R. C.M. van Kruijsdijk, E. van der Wall, and F. L.J. Visseren Obesity and Cancer: The Role of Dysfunctional Adipose Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2569 - 2578. [Abstract] [Full Text] [PDF]